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ABSTRACT 
Objective:  To evaluate the pattern of CNS tumours according to site and age. 
Study Design:  Observational. 
Duration of Study:  1 Jul 2011 to 30 June 2015. 
Patients and Methods:  This is a retrospective audit of CNS tumour registry carried out at our neurosurgical 
center over the period of four years. A total of 653 cases with age range of 1-80 years, both gender and histo-
pathological proven CNS tumours were included in the study. Data of age, gender, location and histological 
diagnosis was obtained from the patient’s clinical records and entered in study proforma. Data was analyzed by 
using SPSS (version-17) with descriptive statistics. 
Results:  Overall the Supra-tentorial tumours were 69.52% with commonest site of Parietal in 24.0% and 
histology of Glioblastoma Multiforme (GBM) in 37.0%. Infra-tentorial tumours were 16.84% with commonest site 
of Cerebellar in 53.63% and histology of Primitive Neuroectodermal Tumours (PNET) in 26.36%. Sellar tumours 
were 6.27% and Spinal tumours 7.35% with commonest being Neurofibroma in 39.58% cases. Metastases in CNS 
were found in 6.38% cases. 
Conclusion:  This analysis depicts that most of the supratentorial tumours of adult age are neuroepithelial in 
lobar areas especially of GBM type while in children the more common tumours are infratentorial, in cerebellar 
area and of PNET origin. The audit will help us to stratify our workload management and formulate tumour 
pathways. 
Keywords:  Central Nervous System, Tumour registry, GBM, PNET. 
Abbreviations:  CNS: Central Nervous System. PNET: Primitive Neuroectodermal Tumours. WHO: World Health 
Organization. MRI: Magnetic Resonance Imaging. MDT: Multi-Disciplinary Team. CAP: CT Chest Abdomen 
Pelvis. GA: General Anesthesia. CBTRUS: Central Brain Tumour Registry of the United States. 
 
INTRODUCTION 
Incidence of central nervous tumours have increased 
over the past few decades.
1
 Many models exist in dev-
eloped world with national tumour registry programs 
specifically in United States of America (USA), Eng-
land and other countries are following these.
1,2
 How-
ever due to loose administration and irregular resource 
management of health care in Pakistan nothing of that 
pattern or magnitude can be realized in near future. 
Some hospitals in Pakistan do provide closed com-
munity comprehensive health coverage which can 
provide a platform for health statistics of their depen-
dent population according to World Health Organizat-
ion (WHO) 2007 classification of CNS tumours to 
document the tumour cases.
3
 
 Overall incidence in USA of all primary malignant 
and non-malignant CNS tumours is 21.42 cases per 
100,000 population, while in adults 10.08 cases per 
100,000 and in children 5.3 cases per 100,000 popu-
lation.
4
 In England, around 4,700 males and around 
4,700 females were diagnosed with a brain, other CNS 
or intracranial tumour in 2011 and the most common 
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types of CNS tumours in England in 2006 – 2010 were 
astrocytomas (34%) and meningiomas (21%).
5
 
 Clinical presentations vary according to age, site 
of tumour and tumour histology. In Pakistan there is 
no national tumour registry to evaluate the statistics 
and identify burden of CNS tumours, hence guide cli-
nicians to formulate specific tumour management 
pathways. Therefore we conducted this audit to evalu-
ate the bulk of central nervous system tumours accord-
ing to their age, gender, location and histological types 
in this tertiary referral center for neurosurgery. 
 
MATERIAL AND METHODS 
This study was conducted at our Neurosurgery Depart-
ment from 01 Jul 2011 to 30 June 2015 after obtaining 
departmental approval from the Hospital Ethical Com-
mittee. 
 Record of outpatients department (OPD) and In-
door clinical records were used to identify cases eligi-
ble for inclusion in the registry according to age, gen-
der, site of tumour and histopathology for the purpose 
of this study. 
 Convenient non-probability consecutive sampling 
technique was used, out of total 723 cases admitted 
and operated for various CNS tumours, only 653 pati-
ents record was found eligible for the study. Patients 
with complete pre-operative workup, surgical treat-
ment and proven CNS tumours cases of both gender 
and of age ranging from less than 1 year to 80 years 
were included in the study. 70 cases with incomplete 
medical record, lost to follow up and histology like 
arachnoid cysts, epidermoids, dermoids and inconclu-
sive / inconsequential reports were excluded from the 
study. 
 Completeness of medical record included detailed 
history and clinical examination, head Computed 
Tomography (CT) scan, Magnetic Resonance Imaging 
(MRI), laboratory studies, bone scan, CT Chest Abdo-
men Pelvis (CAP) where required and the Multi-Disci-
plinary Team (MDT) meeting decision. 
 Patients were operated under General anesthesia 
(GA) with essential intra-operative monitoring. Surgi-
cal strategies ranged from traditional burr-hole biopsy 
and open biopsies to navigation assisted biopsy/cyto-
reduction for aggressive lesions and complete excision 
of relatively benign tumours according to structure and 
eloquence of the area involved. Post-operative histo-
logy reports reviewed and further follow up/referrals 
and treatment plan identified. 
 Data was recorded on structured proforma sheets. 
The parameters recorded were age, gender, site of les-
ion and histology. Data was analysed by descriptive 
statistics in terms of frequencies, percentages and 
mean ± standard deviation using SPSS (Version 17). 
Descriptive variables were analysed using a univariate 
analysis. 
 
RESULTS 
Analysis of 653 CNS tumours revealed that bulk of 
patients were in 4
th
 decade with mean age of 37.71 
years (±17.621). Over all incidence rate was 69.8% in 
males, and 30.2% in females with male to female ratio 
of 2.31. 
 Keeping in view the site of CNS tumours, Supra-
tentorial was the most favoured site with 454 cases and 
Parietal lobe involvement was commonest in this 
category in 109 cases. Infra-tentorial tumours were 
recorded in 110 cases with commonest site involved 
was Cerebellum in 59 cases. Other common sites were 
Spinal tumours in 48 cases and Sellar tumours in 41 
cases (Table 1). 
 Histologically predominantly seven groups were 
identified with commonest were Glial cell tumours in 
53.74% cases followed by cranial and spinal nerve 
tumours, meningiomas, embryonal tumours, meta-
stases, pituitary and ependymomas in 9.64%, 8.42%,
 
Table 1:  Various CNS tumours by Morphology and site of tumours. 
 
CNS Tumours by Histology and Site: Total 653 cases 
Histological Group Number of Cases % of all CNS Tumours 
Glial cell tumours (Astrocytoma, glioma, Oligodendroglioma) 351 53.74% 
Ependymomas 26 3.98% 
Meningiomas 55 8.42% 
Pituitary 41 6.27% 
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Cranial and spinal nerve tumours 63 9.64% 
Embryonal tumours 43 6.58% 
Metastases 42 6.38% 
Other tumour types 29 4.54% 
Unknown or unspecified type 3 0.45% 
Site of tumours Number of cases % of all CNS tumour cases 
Supra-tentorial 454 69.52% 
Infra-tentorial 110 16.84% 
Sellar 41 6.27% 
Spinal 48 7.35% 
commonest supra-tentorial site (Parietal) 109 24% 
Commonest infra-tentorial site (Cerebellar) 59 53.63% 
 
 
 
Fig. 1:  Scatter plot showing relationship of age and common tumour histology. 
Zahid Hussain, et al 
-23-         Pak. J. of Neurol. Surg. – Vol. 20, No. 1, Jan. – Mar., 2016 
 
Fig. 2:  Scatter plot showing relationship of common sites and tumour histology. 
 
6.58%, 6.38%, 6.27% and 3.98% respectively (Table 
1). 
 The most common glial cell tumour was GBM in 
this series168 cases and was also the most common 
supratentorial adult tumour (37.0%). The commonest 
paediatric age tumour was PNET in 29 cases and 
also predominantly involving infratentorial region 
(26.36%). Spinal tumours accounted for 7.35% with 
commonest being neurofibroma in spinal group 
(39.58%). Metastases were the fifth commonest tum-
our found in 42 cases of CNS tumours (Fig. 1). 
 Overall the most common histology was GBM 
(n = 168), followed by Meningioma (n = 55) and 
Astrocytoma – WHO Grade II (n = 47) (Fig. 1). 
 
DISCUSSION 
Analysis of various CNS tumours was based upon age, 
gender, site of tumour and histology. The Mean age 
was in late 4
th
 decade which is slightly younger than 
other local studies.
6,7
 Males were predominant popu-
lation in our study with male to female ratio of 2.31 
which is in concordance with other local studies.
8,9
 
The incidence has been quoted higher in females in 
international study but that is the reflection of nation-
wide study with cent per cent population involvement 
contrary to our one center study which may not be 
representative of the whole population across Pakis-
tan.
2,5,10
 
 The most common location of CNS tumours in our 
study was supra-tentorial in 69.52% followed by infra-
tentorial (16.84%), spinal (7.35%) and sellar (6.27%) 
with commonest supra-tentorial site Parietal lobe in 
24.0% and commonest infra-tentorial site cerebellum 
in 53.63% which is congruent with national/ interna-
tional studies.
11-13
 
 Histologically GBM was the commonest tumour 
in 37.0% of supratentorial location and also the most 
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common CNS tumour in whole series (25.73%). The 
higher incidence of GBM is our series in comparison 
with Central Brain Tumour Registry of the United 
States (CBTRUS) database showed high congruency 
of findings and other local studies.
2,14-16
 Mean age at 
diagnosis for GBM was 46.48 years (±17.81). This 
younger age is in contrast to the international litera-
ture, where mean age at diagnosis is 64 years.
2,10,17,18
 
 Meningiomas were found the second most com-
mon histology forming 8.42% of CNS tumours regis-
try in our series which is in contrast to international 
tumour registry studies of CBTRUS and Cancer Rese-
arch UK but comparable to national studies.
2,5,14,19,20
 
 Chen L et al quoted 38.0% and 36.5% for the abo-
ve two main histologies, whereas fact sheet from CBT-
RUS showed 33.7% and 35.5% respectively which is 
also reflected in a study by Lee CH et al.
2,19,20
 Menin-
giomas are slow growing benign tumours which are 
less symptomatic and many patients report when they 
become floridly symptomatic with fairly large tumours 
and moreover being a developing country imaging 
facilities are not available in remote areas may be the 
main reasons for statistical discrepancy. 
 Astrocytoma – WHO Grade II was the third most 
common histology based CNS tumour in our series 
(7.2%) and oligodendroglial tumours made 6.89% of 
the registry over four years. Hashmi AA et al also 
reported rise in incidence of oligodendroglial tumours 
in Pakistan and the above incidence is also congruent 
with international studies.
15,21
 
 Pituitary tumours made 6.27% representation in 
our series which is congruent with CBTRUS of 8.6% 
and Malik S et al.
2,22
 
 Metastases to CNS were found in 6.38% of our 
series, which is statistically comparable to local stud-
ies and study by Chen L et al.
7,19
 Detection of brain 
micro metastases by high resolution stereotactic mag-
netic resonance imaging is a newer modality to early 
diagnosis and probably more treatable metastases in 
the brain.
23
 However in our series only the surgically 
operated cases have been represented excluding the 
non-operable, non-operated and multifocal metastases. 
 Children and early teens had PNET as the commo-
nest infra-tentorial (31.81%) CNS tumour and 3.22% 
of the whole series. In Comparison with the CBTRUS 
database and Asirvatham JR et al and Pinho RS et al, 
statistical drifts were seen due to many factors of bias 
in the study population and not representative of the 
scale of comparison.
2,24,25
 
 Nevertheless this study and its results will help us 
stratify our clinical priorities in establishing central 
database with unique identification numbers for pati-
ents, which can be tracked nationwide through various 
oncology hospitals/departments and also help us plan 
the latest infrastructure development to deal with 
clusters of tumour patients in specific tumour path-
ways e.g. high grade glioma pathway of 6 weeks. 
 The limitations of our study include selection bias 
due to intention to treat patients, single neurosurgical 
center series, retrospective collection of data and small 
sample size not representative of the whole country 
population. Further larger population based, prospec-
tive study with oncology treatment arm and outcomes 
may help in finding refined indices of the CNS tum-
ours registry and national average prognosis. 
 
CONCLUSION 
This analysis conformed to worldwide data that most 
of the supratentorial tumours of adult age were neuro-
epithelial in lobar areas especially of GBM type while 
in children the more common tumours were infraten-
torial, in cerebellar area and of PNET origin. The stu-
dy highlights the need to prioritize setting up national/ 
provincial tumour registry, formulation of tumour 
pathways for patients and resources recruitment for 
their implementation. 
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